🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT04112992
Recruiting Observational

An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects

NCT04112992 · tracked via the Priya Life Science India tracker
Sponsor
AO Innovation Translation Center
Phase
Observational
Started
2024-07-03
Last updated
2025-08-29

Condition(s) studied

Limb FractureBone Loss

Investigational drug(s) / intervention(s)

Any treatment that is used for a defect of any long bone

Any treatment that is used for a defect of any long bone: Any treatment that is used for a defect of any long bone. All treatments are based on individual clinician's judgement and the patient characteristics. The registry does not dictate any specific treatment.

Study summary

Long bone defect (LBD) is defined as a focalized loss of bone tissue in any long bone of the upper or lower extremity. Long bone defects are a complex problem, that may arise as a complication of many different pathologies, such as trauma, tumors or infection. Whereas post-traumatic defects are the largest group.

Reports estimate that there are almost 4 million bone grafting procedures worldwide per year. However, limb reconstruction in the context of a bony defect is challenging and up to date there is little evidence and treatment recommendations.

In a multi-national approach, the aim of this project is to set up an international, multicenter registry to gather information and details on prevalence or incidence, current treatments, complications and outcome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Skeletally mature * Post traumatic bone defect \> 2 cm either * initially after injury or * after surgical debridement * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the clinical investigation according to the registry plan * Signed and dated EC/IRB approved written informed consent OR * Written consent provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent Exclusion Criteria: * Any oblique defect that has less than 8cm expansion when adding the defect size of all four cortices * Any not medically managed severe systemic disease * Pregnancy * Prisoners * Participation in any other medical device or medicinal product registry within the previous 3 months that could influence the results of the present registry

Primary outcome measure(s)

Trial sites (21)

FacilityCityRegionStatus
Cedar Sinai Los Angeles California Recruiting
Sinai Hospital of Baltimore Baltimore Maryland Recruiting
John Hunter Hospital Newcastle Australia Recruiting
Hospital Municipal Miguel Couto Serviço de Ortopedia e Traumatologia Rio de Janeiro Brazil Recruiting
Hospital Base Valdivia Valdivia Chile Recruiting
Hospital Universitario de la Samaritana Bogotá Colombia Suspended
Hospital Pablo Tobon Uribe Medellín Colombia Recruiting
University Hospital Frankfurt Frankfurt Germany Recruiting
Universitätsspital Gießen Giessen Germany Recruiting
Universitätsklinikum Heidelberg (Unfallchirurgie) Heidelberg Germany Terminated
Universitätsklinikum Münster (Klinik und Poliklinik für Unfall-, Hand- und Wiederherstellungschirurgie) Münster Germany Recruiting
Krankenhaus Johanneum Wildeshausen Germany Not Yet Recruiting
Paras HMRI Hospital Patna Patna India Recruiting
Academisch Ziekenhuis Maastricht (Dept. of Surgery) Maastricht Netherlands Recruiting
Radboud University Medical Center Nijmegen Netherlands Recruiting
Tygerberg Hospital Cape Town South Africa Not Yet Recruiting
Kyungpook National University Hospital (Orthopaedics) Daegu South Korea Recruiting
Universitätsspital Zürich (Klinik für Traumatologie) Zurich Switzerland Recruiting
Central Hospital of Border Guard Service of Ukraine Kyiv Ukraine Not Yet Recruiting
Leeds General Infirmary University Hospital (Trauma & Orthopaedic Surgery) Leeds United Kingdom Not Yet Recruiting
Hospital Universitario de Caracas Caracas Venezuela Not Yet Recruiting

More AO Innovation Translation Center trials in India

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04112992 on ClinicalTrials.gov ↗ ← All trials in India